| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 20/09/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:GFOR | Graf Acquisition Corp IV |
| 12/09/2024 | 23:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:GFOR | Graf Acquisition Corp IV |
| 14/08/2024 | 22:05 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NYSE:GFOR | Graf Acquisition Corp IV |
| 23/07/2024 | 14:31 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | NYSE:GFOR | Graf Acquisition Corp IV |
| 22/07/2024 | 23:19 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NYSE:GFOR | Graf Acquisition Corp IV |
| 18/07/2024 | 23:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:GFOR | Graf Acquisition Corp IV |
| 18/07/2024 | 23:52 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NYSE:GFOR | Graf Acquisition Corp IV |
| 12/07/2024 | 22:58 | Edgar (US Regulatory) | Form PRER14A - Preliminary Proxy Soliciting materials | NYSE:GFOR | Graf Acquisition Corp IV |
| 10/07/2024 | 23:21 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] | NYSE:GFOR | Graf Acquisition Corp IV |
| 09/07/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NYSE:GFOR | Graf Acquisition Corp IV |
| 27/06/2024 | 22:34 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] | NYSE:GFOR | Graf Acquisition Corp IV |
| 10/05/2024 | 20:42 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:GFOR | Graf Acquisition Corp IV |
| 29/04/2024 | 23:20 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] | NYSE:GFOR | Graf Acquisition Corp IV |
| 16/04/2024 | 21:07 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NYSE:GFOR | Graf Acquisition Corp IV |
| 01/04/2024 | 22:01 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NYSE:GFOR | Graf Acquisition Corp IV |
| 19/10/2023 | 23:27 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under the Securities Act of 1933 | NYSE:GFOR | Graf Acquisition Corp IV |
| 19/10/2023 | 23:23 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NYSE:GFOR | Graf Acquisition Corp IV |
| 10/10/2023 | 23:01 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial ownership | NYSE:GFOR | Graf Acquisition Corp IV |
| 29/09/2023 | 22:16 | Edgar (US Regulatory) | Form CERT - Certification by an exchange approving securities for listing | NYSE:GFOR | Graf Acquisition Corp IV |
| 22/09/2023 | 18:55 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:GFOR | Graf Acquisition Corp IV |
| 15/08/2023 | 18:07 | GlobeNewswire Inc. | Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination | NYSE:GFOR | Graf Acquisition Corp IV |
| 05/06/2023 | 14:33 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NYSE:GFOR | Graf Acquisition Corp IV |
| 01/06/2023 | 12:05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NYSE:GFOR | Graf Acquisition Corp IV |
| 23/05/2023 | 16:30 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NYSE:GFOR | Graf Acquisition Corp IV |
| 17/05/2023 | 03:56 | Business Wire | Graf Acquisition Corp. IV Currently Has Proxies from More Than 65% of its Stockholders to Approve Extension | NYSE:GFOR | Graf Acquisition Corp IV |
| 15/05/2023 | 22:19 | Edgar (US Regulatory) | Quarterly Report (10-q) | NYSE:GFOR | Graf Acquisition Corp IV |
| 03/05/2023 | 22:41 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NYSE:GFOR | Graf Acquisition Corp IV |
| 15/04/2023 | 02:19 | GlobeNewswire Inc. | NKGen Biotech, Inc. to Become Publicly Traded Company via Business Combination with Graf Acquisition Corp. IV | NYSE:GFOR | Graf Acquisition Corp IV |
| 10/04/2023 | 23:23 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NYSE:GFOR | Graf Acquisition Corp IV |
| 23/03/2023 | 22:51 | Business Wire | Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination | NYSE:GFOR | Graf Acquisition Corp IV |